DIA 2018 Global Annual Meeting

Component Type: Session
Level: Intermediate

In the current era of Precision Medicine, individuals and healthcare systems desire to create massive amounts of genomic data associated with various diseases. Scientists need large genomic datasets to identify the root causes of these diseases in order to develop cures for them. However, growth of the genomic data market is hindered by data fragmentation, lack of data standardization and slow data acquisition. Blockchain technology can be used to eliminate the middleman and empower people to own their personal genomic data. This will effectively lower sequencing costs and enhance data privacy, resulting in growth of actionable genomic data to fight disease. Having open protocols will leverage genomic data growth by enabling data buyers to efficiently aggregate standardized data from many individuals and genomic databanks.

This session will discuss how the current state of genomic data creation can be impacted by Blockchain technology, and address the future state of genomic data sharing and security as new technological advancements at the intersection of healthcare and information technology are developed.

Learning Objectives

Define the major obstacles in the creation of genomic data sets; Describe how block chain technology can enable genomic data creation, ensure its security, and allow for its sharing; Discuss the future state of genomic research, genomic data security, genomic data standardization and data sharing between individuals and companies as whole genome sequencing costs continue to decrease.

Chair

Dennis Grishin, MS